Skip to main content
Clinical Cardiology logoLink to Clinical Cardiology
. 2009 Feb 3;23(1):47–50. doi: 10.1002/clc.4960230109

Incidence and significance of profound hypotension during dobutamine stress echocardiography

Milind R Dhond 1,, Teresa B Whitley 1, Satnam Singh 1, Thanh T Nguyen 1, William J Bommer 1
PMCID: PMC6654861  PMID: 10680029

Abstract

Background: Mild hypotension (drops of systolic blood pressure of ≥20 mmHg) occurs in 14‐‐38% of dobutamine stress echo (DSE) and carries a good prognosis for subsequent cardiac events. The incidence and significance of more profound hypotension (PH) (≥ 50mmHg) is unknown.

Hypothesis: The aim of the study was to determine the incidence of PH during DSE and its prognosis for subsequent cardiac events.

Methods: We reviewed 617 DSE performed at our institution between 1992 and 1996 and identified two DSE subgroups. The first group (PH group) consisted of all patients with PH during DSE. A second group was selected with baseline characteristics similar to the PH group but without PH during DSE (non‐PH group). Follow‐up was by a physician chart review and direct telephone contact. Cardiac event rates were determined for hard [myocardial infarction (MI), or cardiac death] and soft (angina, congestive heart failure, coronary angioplasty, or coronary bypass surgery) events occurring after the DSE.

Results: Of the 617 DSE performed, 16 (3%) patients developed PH (PH group) during DSE, with 13 showing no inducible ischemia. The hard and soft cardiac event rate in this 13 PH group was 46% (mean follow‐up of 28.7 ± 18 months). Of the non‐PH group, 32 patients had a negative DSE with a coronary event rate of 12.5%. Profound hypotension correlated with a significantly higher cardiac event rate (p < 0.02).

Conclusions: The incidence of PH during DSE is low (3%) and appears to predict a worse prognosis for subsequent cardiac events.

Keywords: hypotension, dobutamine stress echo, incidence, prognosis.

Full Text

The Full Text of this article is available as a PDF (401.1 KB).

Reference

  • 1. Pierand LA, De Landsheere CM, Berthe C, Rigo P, Kulbertus HE: Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: Comparison with positron emission tomography. J Am Coll Cardiol 1990; 15: 1021–1031 [DOI] [PubMed] [Google Scholar]
  • 2. Previtali M, Poli A, Lanzarini L, Fetiveau R, Mussini A, Ferrario M: Dobutamine stress echocardiography for the assessment of myocardial viability and ischemia in acute myocardial infarction treated with thrombolysis. Am J Cardiol 1993; 72: 124G–30G [DOI] [PubMed] [Google Scholar]
  • 3. Carlos ME, Smart SC, Wynsen JC, Sagar KB: Dobutamine stress echocardiography for risk stratification after myocardial infarction. Circulation 1997; 95: 1402–1410 [DOI] [PubMed] [Google Scholar]
  • 4. Sicari R, Picano E, Landi P, Pingatore A, Bigi R, Colletta C, Heyman J: Prognostic value of dobutamine‐atropine stress echocardiography early after acute myocardial infarction. J Am Coll Cardiol 1997; 29: 254–260 [DOI] [PubMed] [Google Scholar]
  • 5. Williams MJ, Odabashian J, Lauer MS, Thomas JD, Marwick TH: Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. J Am Coll Cardiol 1996; 27: 132–139 [DOI] [PubMed] [Google Scholar]
  • 6. Mazeika PK, Nadazdin A, Oakley CM: Prognostic value of dobutamine echocardiography in patients with high pretest likelihood of coronary artery disease. Am J Cardiol 1993; 71: 31–39 [DOI] [PubMed] [Google Scholar]
  • 7. Marcovitz PA, Bach DS, Mathias W, Shayna V, Armstrong WF: Paradoxic hypotension during dobutamine stress echocardiography: Clinical and diagnostic implications. J Am Coll Cardiol 1993; 21: 1080–1086 [DOI] [PubMed] [Google Scholar]
  • 8. Mazeika PK, Nadazdin A, Oakley CM: Clinical significance of abrupt vasodepression during dobutamine stress echocardiography. Am J Cardiol 1992; 69: 1484–1486 [DOI] [PubMed] [Google Scholar]
  • 9. Sanmarco ME, Pontius S, Selvester RH: Abnormal blood pressure response and marked ischemic ST‐segment depression as predictors of severe coronary artery disease. Circulation 1980; 61: 572–578 [DOI] [PubMed] [Google Scholar]
  • 10. Marshall R, Greenberg M, Kokkinos P, Weissman N, Fletcher R, Fernocola D: Does myocardial ischemia occur during left ventricular cavity obliteration? A simultaneous stress echocardiography and myocardial perfusion study (abstr). J Am Soc Echocardiogr 1998; 11 (5): 547 [Google Scholar]
  • 11. Tanimoto M, Pai RG, Jintapakorn W, Shah PM: Mechanisms of hypotension during dobutamine stress echocardiography in patients with coronary artery disease. Am J Cardiol 1995; 76: 26–30 [DOI] [PubMed] [Google Scholar]
  • 12. Heinle SK, Tice FD, Kisslo J: Hypotension during dobutamine stress echocardiography: Is it related to dynamic intraventricular obstruction? Am Heart J 1995; 130: 314–317 [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES